Rhenman & Partners Asset Management AB

CIK 0001599882 · STOCKHOLM, null · Quarter end: 2026-06-30 · Filed on: 2026-08-13 · Open the SEC source

Rhenman & Partners Asset Management AB reported 99 positions worth $1.06B as of June 30, 2026 (13F filed August 13, 2026). Largest holding: UNH (3.7%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$1.06B
2026 Q2
Positions
99
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
25.1%
Est. Net Flow (Q)
2026 Q2
10 / 99 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1UNHUNITED HEALTH GROUP INCSH$38.9M3.67%93,600
2CVSCVS HEALTH CORPSH$28.9M2.73%279,374
3AZNASTRAZENECA PLCSH$28.5M2.69%151,500
4MRKMERCK & CO INCSH$27.4M2.59%213,500
5LLYLILLY ELI & COSH$26.8M2.53%22,315
6ABBVABBVIE INCSH$24.4M2.30%96,775
7ALHCALIGNMENT HEALTHCARE INCSH$23.7M2.24%997,083
8EWEDWARDS LIFESCIENCES CORPSH$23.5M2.22%260,000
9GILDGILEAD SCIENCES INCSH$22.5M2.13%178,250
10JAZZJAZZ PHARMACEUTICALS PLCSH$21.1M1.99%87,440

The free plan shows the top 10 positions. The remaining 89 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Rhenman & Partners Asset Management AB hold as of Q2 2026?

Rhenman & Partners Asset Management AB reported 99 positions worth $1.06B in its Q2 2026 13F filing. Largest positions: UNH (3.7%), CVS (2.7%), AZN (2.7%), MRK (2.6%) and LLY (2.5%).

What did Rhenman & Partners Asset Management AB buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Rhenman & Partners Asset Management AB sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.